SHILPA MEDICARE
Back to Balance Sheet
|
SHILPA MEDICARE Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹14 Cr | ₹55 Cr | ₹47 Cr | ₹42 Cr | ₹48 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of SHILPA MEDICARE ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2023 | ₹14 Cr |
Mar2022 | ₹55 Cr |
Mar2021 | ₹47 Cr |
Mar2020 | ₹42 Cr |
Mar2019 | ₹48 Cr |
How is Deferred Tax Assets / Liabilities of SHILPA MEDICARE Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2023 | ₹14 Cr | -74.33 | |
Mar2022 | ₹55 Cr | 15.77 | |
Mar2021 | ₹47 Cr | 12.62 | |
Mar2020 | ₹42 Cr | -11.93 | |
Mar2019 | ₹48 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of SHILPA MEDICARE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SHILPA MEDICARE | ₹4,821.5 Cr | 0.3% | -7% | 105% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹351,910.0 Cr | -4.8% | -3.5% | 59.7% | Stock Analytics | |
CIPLA | ₹119,369.0 Cr | 2.4% | 5.2% | 59.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹112,930.0 Cr | 5.9% | 10.8% | 21.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹106,515.0 Cr | -2.8% | 11.3% | 112.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹98,161.7 Cr | 1.8% | -5.4% | 31.5% | Stock Analytics |
SHILPA MEDICARE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SHILPA MEDICARE | 0.3% |
-7% |
105% |
SENSEX | 1.9% |
2.1% |
21.7% |
You may also like the below Video Courses